INTRODUCTION
Hematopoietic stem and multipotential progenitor cells (HSPCs) reside in specialized environments called stem cell niches in the medulla of the bone. Whereas the endosteal ''osteoblastic niche'' (composed of a subset of specialized osteoblasts in the inner surface of the bone cavity) is believed to maintain HSPCs in a quiescent state in poorly perfused regions, the ''vascular niche'' (adjacent to the bone marrow [BM] vasculature) may serve as a transit pathway that senses environmental signals and shuttles HSPCs out of the BM (Kiel et al., 2007; Lymperi et al., 2010; Ehninger and Trumpp, 2011) .
In hematologic malignancies such as leukemias and myeloproliferative neoplasms, the spleen and the liver resume their fetal hematopoietic functions causing organomegaly in a process called extramedullary hematopoiesis (Kraus et al., 1998; O'Malley et al., 2005) . Symptomatic splenomegaly is common and causes significant morbidity in these patients. An enlarged spleen can cause pain, early satiety, pancytopenia, portal hypertension, and hypercatabolic changes. Although not fully understood, extramedullary hematopoiesis is believed to result from conditions that disrupt the BM microenvironment, facilitating the egress of progenitor and precursor cells. Mobilization of hematopoietic stem and multipotential progenitor cells (HSPCs), mainly to the spleen, may provide a more permissive microenvironment for proliferation and myeloid differentiation (Morrison et al., 1997) . Deregulation of this system contributes to the progression of myeloproliferative diseases (Perry and Li, 2007; Raaijmakers et al., 2010) .
ABCA1 and ABCG1 play an important role in cholesterol homeostasis by promoting cellular cholesterol efflux to lipidpoor apoA-I and HDL particles, respectively Yvan-Charvet et al., 2007) . Intrinsic deficiency of these transporters in HSPCs led to expansion and proliferation of HSPCs in BM Yvan-Charvet et al., 2007 . However, this mechanism did not explain splenomegaly and myeloid cell infiltration of different organs observed in Abca1
Abcg1
À/À mice. An investigation of these processes led to the discovery of dramatic HSPC mobilization in Abca1
mice reflecting increased G-CSF production. Prior studies have identified a feedback loop controlling G-CSF and neutrophil production (Stark et al., 2005) . When macrophages phagocytose apoptotic neutrophils, there is suppression of production of the cytokine IL-23 leading to decreased G-CSF and neutrophil production. Our studies show that the production of IL-23 was increased in macrophages and dendritic cells deficient in ABCA1 and ABCG1 and that the resulting increase in G-CSF led to changes in the bone marrow milieu favoring release of HSPCs into the circulation.
RESULTS

Enhanced HSPC Mobilization and Extramedullary Hematopoiesis in Abca1
-/-
Abcg1 -/-Mice
Flow cytometry analysis of HSPC, common myeloid progenitors (CMP) and granulocyte macrophage progenitors (GMP), and colony forming unit assays of multipotential progenitors (CFU-GEMM) and GMP (CFU-GM) revealed a 3-fold increase in the number of these cells in the blood of chow-fed Abca1 indicating enhanced HSPC, CMP, and GMP mobilization. Circulating LSK Flk2 À cells and LSK CD34 À cells were also proportionally increased in these mice ( Figure S1B ). This was associated with a parallel 3-fold increase in the number of HSPCs, CMP, and GMP progenitors and CFU-GEMM/GM in the spleen ( Figures 1C, 1D , and S1D) and liver (Figures 1E, 1F, and S1E) and increased CFUs in lung and heart cell extracts ( Figure S1C ). These changes indicate HSPC mobilization and extramedullary hematopoiesis in multiple organs in Abca1 progenitors (CMP) and granulocye/macrophage progenitors (GMP) from (A) the blood, (C) the spleen, or (E) the liver of chow fed WT and Abca1
mice. Also displays are colony-forming unit assays of multipotential progenitors and granulocyte macrophage progenitors (CFU-GEMM and CFU-GM, respectively) from (B) the blood, (D) the spleen, or (F) the liver of chow fed WT and Abca1 
Abcg1
À/À HSPCs, suggesting that the enhanced HSPC mobilization in these mice involved a cell-extrinsic factor ( Figure 2B ). This was consistent with the lack of alteration in the cell-surface expression of key cytokine receptors involved in the migratory response of HSPCs in Abca1
À/À mice including the integrin a4b1 receptor (VLA4), the glycoprotein CD44, the stem cell growth factor receptor c-kit, and angiopoietin receptor Tie2 (Figure S2D ). Cell-surface expression of CD47 in BM and peripheral HSPCs, used by these cells to hide from normal scavenging by myeloid cells (Jaiswal et al., 2009) , was also unaltered in Abca1 Figure S2E ). In addition, analysis of the circadian oscillation of the number of CFU showed that the appearance of HSPCs in the blood during the early phase of the diurnal cycle was increased 2.7-fold in WT recipients transplanted with Abca1 À/À Abcg1 À/À BM compared to 1.7-fold in controls ( Figure S2F ). This pattern suggested that the appearance of HSPCs rather than their clearance from the blood was increased in these mice. Thus, in contrast to the cell-autonomous effect of these transporters on HSPC proliferation (YvanCharvet et al., 2010) , HSPC mobilization in Abca1
mice was mediated by cell-extrinsic factors.
G-CSF Dependence of HSPC Mobilization in Abca1
We next tested the roles of IL-3, CXCL2 (or macrophage inflammatory protein, MIP2), and G-CSF, factors that were previously shown to be increased in Abca1 et al., 2007, 2008) and also known to have key roles in the regulation of HSPC mobilization (Guillaume et al., 1993; Fibbe et al., 1999; Metcalf, 2008; Greenbaum and Link, 2011) . Although injection of IL-3Rb or CXCL2 blocking antibodies did not prevent the enhanced HSPC mobilization of WT recipients transplanted with Abca1
izing antibody caused a major reduction in the mobilization of HSPCs in these mice ( Figure 2C ) and in the number of HSPCs in the spleen (data not shown). Alteration in the expression of the G-CSF receptor was unlikely to explain these effects because there was no significant change in its cell-surface expression or mRNA level in different BM populations of Abca1 Figures S3A-S3C ). Consistent with a lack of expression of G-CSF receptor on HSPCs (Liu et al., 2000) , addition of G-CSF to in vitro BM cultures did not promote expansion of either WT or Abca1 À/À Abcg1 À/À HSPCs (Figure S3D) , and the G-CSF neutralizing antibody did not modulate the number of BM HSPC in these mice ( Figure S3E) . The increased plasma G-CSF in Abca1
BM-mediated effect ( Figure 2D ). Thus, the absence of ABCA1 and ABCG1 in myeloid BM-derived cells led to an increase in plasma G-CSF that in turn caused increased mobilization of HSPCs.
Consistent with the central role of interleukin-17 (IL-17) as a potent inducer of G-CSF (Fossiez et al., 1996) , we found increased plasma IL-17 levels in Abca1 À/À Abcg1 À/À BM-transplanted mice ( Figure 3A ). We also showed that the administration of an IL-17 blocking antibody was able to normalize both plasma G-CSF levels ( Figure 3B ) and CFU numbers ( Figure 3C ) in WT recipients transplanted with Abca1
production of IL-17 can be mediated by commensal bacteria from the intestinal flora (Ivanov et al., 2008) or by the secretion of interleukin-23 (IL-23) from splenic phagocytic cells (Stark et al., 2005) . Despite hypertrophy of intestinal Peyer's patches in Abca1 Yvan-Charvet et al., 2010) , treatment of these mice with broad spectrum antibiotics including vancomycin (Yvan-Charvet et al., 2010) to suppress segmented filament bacteria involved in the induction of intestinal Th17 (Ivanov et al., 2008) did not reduce their plasma IL-17 or G-CSF levels ( Figures 3D and S3F ). In contrast, we found a 4-fold increase in IL-23 concentration in the spleen of these mice, an effect that was dependent on the absence of ABCA1 and ABCG1 in BM-derived myeloid cells ( Figure 3E ). Treatment with an IL-23R neutralizing antibody reduced both plasma IL-17 and G-CSF levels in WT recipients transplanted with Abca1 Figures 3F and S3G) and also the number of CFU in the blood ( Figure S3H ). Figure 4A) , with a parallel increase in the number of CFU in the blood ( Figure 4B ). This was also associated with an increase in plasma IL-17 ( Figure 4C ) and G-CSF ( Figure 4D Figure 4F ). Thus, in addition to its known role in promoting granulopoiesis (Stark et al., 2005) , IL-23/IL-17/G-CSF signaling is now shown to be associated with enhanced HSPC mobilization. Cholesterol efflux pathways in macrophages and dendritic cells suppressed this signaling pathway.
ABCA1 and ABCG1 Deficiency in Macrophages and
Increased proteolytic cleavage of CXCR4 in Abca1
HSPCs is not sufficient to promote their mobilization. These experiments have been described in the Supplemental Experimental Procedures available online.
Mice due to Decreased Expression in Osteoblasts and Nestin + Progenitors
These observations suggested that an alternative pathway was involved in the enhanced HSPC mobilization of Abca1
Recent evidence suggests that G-CSF may decrease Cxcl12/SDF-1 expression (Semerad et al., 2005) . Cxcl12/SDF-1 was reduced by 25% in BM fluid of WT recipients transplanted with Abca1 À/À Abcg1 À/À BM, with or without CXCR4 lentiviral overexpression ( Figure S4J ). There was a 50% decrease in Cxcl12/SDF-1 mRNA expression and protein content in the BM ( Figure S5A ). As the number of dipeptidyl peptidase-4 (CD26/DPPIV)-positive cells measured by flow cytometry was reduced by 60% in Abca1 Figure S5B ), this suggested that the altered production rather than the cleavage of Cxcl12/SDF-1 was impaired in these mice. Consistent with this observation, the number of 
Cell Stem Cell ABCA1, ABCG1, and HDL Regulate HSPC Mobilization SDF-1-expressing reticular (CAR) cells (Sugiyama et al., 2006) but not non-SDF-1-expressing cells was reduced in Abca1 Figure S5C ). Together these findings suggested that the enhanced HSPC mobilization of Abca1
BM-transplanted mice could not be attributed to increased neutrophil elastase 2-dependent CXCR4 cleavage but rather reflected reduced SDF-1/Cxcl12 mRNA expression. In addition, we found that the 50% decrease in SDF-1/Cxcl12 BM fluid content was mainly attributable to the lack of ABCA1 and ABCG1 in BM-derived myeloid cells ( Figure 5A ). Endothelial cells, osteoblasts (OBs), and Nestin + mesenchymal stem cells (MSCs) were reported to be the major Cxcl12/SDF-1-expressing cell types within the BM (Dar et al., 2005; Semerad et al., 2005; Christopher et al., 2009; Mé ndez-Ferrer et al., 2010) . To gain more insight into the regulation of Cxcl12/SDF-1 in Abca1 Figure S5D ). High osteocalcin and Figure S5F ). These data were consistent with similar bone mineral density measured in vivo by DEXA ( Figure S5G ). Fourier transform infrared imaging (FTIRI) analysis of tibial cortical bone also revealed similar mineral/matrix, carbonate/phosphate and collagen crosslink ratio, as well as crystallinity between WT and Abca1 À/À Abcg1 À/À mice (Figure S5H) . Thus, the enhanced HSPC mobilization in Abca1 À/À Abcg1 À/À mice was not the consequence of altered mineral or matrix bone properties. However, a decrease in the heterogeneous distribution of bone tissue material properties was noted for almost all of the measured FTIRI parameters in the bone of Abca1 Figure 5C ). This reflected reduced bone remodeling with fewer regions of newly formed bone tissue (Gourion-Arsiquaud et al., 2010) and suggested some specificity in osteoblastic lineage fate in these mice. Although the reduced number of Nestin + MSCs in Abca1
reach significance ( Figure 5D ), there was a pronounced 3-fold decrease in the number of Lin
lineage cells ( Figure 5D ). We also observed similar reductions in Lin 
Depletion of BM Macrophages Contributes to Reduced
Cxcl12/SDF-1 Expression in Abca1
Recent studies have highlighted a role of BM macrophages in supporting osteoblast differentiation and SDF-1/Cxcl12 production (Winkler et al., 2010; Christopher et al., 2011; Chow et al., 2011 (Chow et al., 2011) that are localized in different hypoxic area of the BM (Ehninger and Trumpp, 2011) . The gating strategy is provided in Figure S6A . Both populations of macrophages were dramatically reduced, by 2-and 4-fold, respectively, in WT recipients transplanted with Abca1
BM, and this was dependent on a role of ABCA1 and ABCG1 within the BM-derived myeloid population as shown by the fact that transplantation of WT BM into Abca1
almost completely reversed this loss ( Figures 6A and 6B) . Interestingly, the role of G-CSF in mediating HSPC mobilization was recently shown to involve the G-CSF receptor within cells of the monocytic lineage (Christopher et al., 2011) . Therefore, we next took advantage of the finding that the IL-17 neutralizing antibody reduced the plasma G-CSF levels in these mice. Treatment of WT recipients transplanted with Abca1 À/À Abcg1 À/À BM with this antibody largely rescued the loss of both BM macrophage populations ( Figures 6C and 6D ) and the reduced SDF-1/ Cxcl12 BM fluid content ( Figure S6B ). Figure S6E ). This revealed that the enhanced IL-23/IL-17/G-CSF axis contributed substantially to the depletion of both BM macrophage populations and subsequent loss of BM SDF-1/Cxcl12 production. Finally, consistent with earlier work (Zhu and Emerson, 2002; Rieger et al., 2009) , in vitro BM cultures showed that G-CSF treatment of Abca1
Abcg1
À/À BM cultures resulted in increased neutrophil but decreased monocyte production, whereas IL-3 treatment increased both neutrophils and monocytes, suggesting that G-CSF instructed hematopoietic progenitor determination to favor neutrophilic over monocytic lineages (Figures S6F and S6G) . Consistent with these findings, we observed that in vitro treatment of WT BM cells with 10% serum from Abca1 À/À Abcg1 À/À mice favored mainly GMP and to some extent MDP expansion compared to WT serum ( Figures 6E, S6H , and S6I), leading to a major increase in the number of neutrophils (Figure 6F ). The use of the G-CSF neutralizing antibody in these cultures revealed that the inhibition of GMP and neutrophil expansion ( Figures 6E and 6F ) was associated with a significant increase in the number of monocytes ( Figure 6F ), indicating that G-CSF acted at the level of GMP to tightly control the leukocyte fate. Thus, we propose that enhanced IL-23/IL-17-dependent G-CSF production by Abca1 À/À Abcg1 À/À splenic phagocytic cells induced HSPC mobilization by altering the fate of GMPs such that there was decreased formation of monocyte/ macrophage-lineage cells and decreased macrophage-dependent osteoblastic support and SDF-1/Cxcl12 production.
Raising HDL-Cholesterol Suppresses HSPC Mobilization in Mouse Models of Hypercholesterolemia and Myeloproliferative Disorders
Expression of the human apoA-I transgene led to reduced plasma G-CSF ( Figure 7A ) and reduced HSPC mobilization in Abca1 À/À Abcg1 À/À BMT mice ( Figure 7B ), providing a mechanism to explain the reversal of extramedullary hematopoiesis, splenomegaly, and myeloid cell proliferation by the apoA-I transgene. This was associated with reduced splenic mRNA expression of IL-23 (data not shown). We next tested whether the suppression of HSPC mobilization by raising HDL levels in Abca1
Abcg1
À/À BM-transplanted mice was peculiar to this model or could be observed as a more general phenomenon in other mouse models of hypercholesterolemia or MPN. We recently reported that hypercholesterolemic Apoe À/À mice exhibited a similar phenotype to Abca1 À/À Abcg1 À/À mice and that infusion of rHDL suppressed their leukocytosis (Murphy et al., 2011) . Apoe À/À mice fed a high fat diet for 4 weeks exhibited a 2-fold increased plasma G-CSF levels ( Figure 7C ) that correlated with their number of circulating HSPCs ( Figure 7D ). Infusion of 80 mg/kg rHDL reduced by approximately 40% not only the plasma G-CSF levels ( Figure 7C ) but also the number of circulating HSPCs in these mice 96 hr postinfusion ( Figure 7D ). Finally, we transplanted BM transduced with retroviruses encoding Flt3-ITD, an oncogenic mutation previously identified in acute myeloid leukemia (AML) that confers a fully penetrant myeloproliferative disorder in mice (Kelly et al., 2002) into either WT or apoA-I transgenic mice. Reduced plasma HDL-cholesterol levels have been previously reported in myeloproliferative disorders (Gilbert et al., 1981; Dessì et al., 1995) . Consistent with these reports, mice bearing the Flt3-ITD mutation exhibited a 1.5-fold decrease in their plasma HDL-cholesterol levels (Figure S7A ) and this was associated with reduced mRNA expression levels of ABCA1 but not ABCG1 in their spleen ( Figure S7B ). Remarkably, there was a 4-fold increase in plasma G-CSF levels and circulating HSPC numbers in mice bearing the Flt3-ITD mutation, and both parameters were markedly reduced by the human apoA-I transgene ( Figures 7E and 7F ). This was associated with reduced mRNA expression of IL-23 in their spleen (Figure S7C) , reduced plasma IL-17 ( Figure S7D ), and suppression of splenomegaly ( Figure S7E ) and splenic HSPC infiltration (Figure S7F) . Finally, the depletion of HSPCs in the BM of mice bearing the Flt3-ITD mutation was prevented by overexpression of the apoA-I transgene ( Figure S7G ), reflecting increased mRNA expression levels of SDF-1/Cxcl12 ( Figure S7H ). Thus, similar mechanisms of HSPC mobilization and reversal by increased HDL levels appear to be involved in both the Abca1
and the Flt3-ITD models of MPNs. Cell Stem Cell ABCA1, ABCG1, and HDL Regulate HSPC Mobilization
DISCUSSION
We have identified a role of cholesterol efflux pathways in limiting the mobilization of HSPCs and prevention of clinically detrimental extramedullary hematopoiesis in mouse models of myeloproliferative disorders. In mice with knockout of transporters ABCA1 and ABCG1 in all BM cells, or exclusively in macrophages or dendritic cells, increased IL-23-dependent production of growth factor G-CSF alters the BM niche leading to HSPC mobilization and infiltration of distant organs. Concordant with a recent study (Rieger et al., 2009) , increased G-CSF acts via GMPs to direct myeloid production toward neutrophils rather than monocytes, eventuating in BM macrophage depletion. Consequently, OB populations as well as the production of SDF-1/Cxcl12 are reduced. Importantly, our findings indicate a beneficial effect of increased HDL levels in preventing or reversing HSPC mobilization and extramedullary hematopoiesis, not only in Abca1 À/À Abcg1 À/À mice and Apoe À/À mice but also in a mouse model of hematological malignancy. These findings suggest a therapeutic application of rHDL infusion in the prevention of extramedullary hematopoiesis in both atherosclerosis and hematologic malignancies. Ley and colleagues have defined a negative feedback loop controlling granulopoiesis in which uptake of apoptotic neutrophils by macrophages and dendritic cells leads to suppression of IL-23 production, decreased release of IL-17 by lymphocytes, and decreased production of G-CSF by bone marrow stromal cells (Stark et al., 2005) . Our results provide evidence that activation of the IL-23/IL-17/G-CSF signaling axis in mice with defective cholesterol efflux pathways leads to increased HSPC mobilization. Moreover, by using cell-specific knockouts of ABCA1 and ABCG1, we show the importance of the cholesterol efflux pathways in macrophages and dendritic cells in the control of IL-23 production. This links the control of HSPC mobilization to cholesterol homeostasis in the innate immune system. In agreement with previous studies (Rieger et al., 2009 ), increased plasma G-CSF levels in Abca1 À/À Abcg1 À/À mice direct hematopoietic lineages in vitro toward neutrophil rather than monocyte/macrophage production. This led to an expansion of neutrophils and loss of macrophage populations in the BM. Neutrophil expansion in Abca1
formed the BM into a highly proteolytic environment (Lé vesque et al., 2002) leading to cleavage of CXCR4 by neutrophil elastase 2 (Petit et al., 2002; Levesque et al., 2003) . However, this alone could not explain enhanced HSPC mobilization because deletion of Elane or lentiviral overexpression of CXCR4 did not rescue this phenotype. Rather, our studies indicated an essential role of reduced BM SDF-1/Cxcl12 production in HSPC mobilization. This is consistent with the recently demonstrated role of decreased SDF-1/Cxcl12 in mediating the effect of G-CSF on HSPC mobilization (Levesque et al., 2004; Semerad et al., 2005; Christopher and Link, 2008) . While macrophage depletion has been shown to promote HSPC mobilization by disruption of the osteoblastic niche through impaired osteoblast (OB) activity and SDF-1/Cxcl12 production (Winkler et al., 2010; Gordy et al., 2011; Chow et al., 2011; Christopher et al., 2011) , the link with endogenous plasma G-CSF appears to be unexplored. Greater endogenous plasma G-CSF induced the loss of BM macrophage populations in Abca1
Abcg1
À/À mice leading to decreased SDF-1/Cxcl12
production. This involved decreases in N-Cadherin + OB subsets and Nestin + progenitors. Previous studies have shown that these cell populations have a key role in maintaining HSPCs in their niche (Lymperi et al., 2008; Visnjic et al., 2004; Mé ndez-Ferrer et al., 2010; Raaijmakers et al., 2010) . Thus, our study shows that cholesterol efflux pathways in splenic macrophages and dendritic cells are linked to control of the osteoblastic niche and HSPC mobilization via the IL23/IL17/G-CSF signaling axis.
Overexpression of the human apoA-I transgene to raise HDL levels prevented the myeloproliferative disorders of Abca1
À/À BM transplanted mice (Yvan-Charvet et al., 2010) .
We now provide evidence that this effect was partly mediated by reduced plasma G-CSF levels and HSPC mobilization. We recently showed that Apoe À/À mice have expanded and proliferating HSPCs (Murphy et al., 2011) . ApoE is expressed on the surface of HSPCs where it appears to interact with ABCA1 and ABCG1 to promote cholesterol efflux (Laffitte et al., 2001; Murphy et al., 2011) . Apoe À/À mice also develop hepatosplenomegaly on WTDs likely reflecting extramedullary hematopoiesis (Murphy et al., 2011) . A recent study has shown that the spleen represents an important reservoir of monocytes in Apoe À/À mice, contributing directly to atherosclerotic lesions (Robbins et al., 2012) . Together with our study, this suggests that extramedullary hematopoiesis resulting from increased G-CSF in Apoe À/À mice plays a role in atherogenesis. Moreover, infusion of cholesterol-poor phospholipid/apoA-I complexes (i.e, rHDL; Murphy et al., 2011) , suppressed plasma G-CSF levels and HSPC mobilization, uncovering a potential anti-atherogenic effect of this treatment. The relevance of the human apoA-I transgene was also tested in a mouse model of myeloproliferative disorder induced by an activating mutation in the Flt3 gene (Flt3-ITD) , the most common mutation associated with acute myeloid leukemia (AML) in humans. Consistent with their myeloproliferative disorder, mice that received BM transduced with retroviruses encoding Flt3-ITD exhibited splenomegaly (Kelly et al., 2002) , and this was associated with increased splenic expression of IL-23, increased plasma G-CSF, and HSC mobilization, likely reflecting an underlying expansion of DCs by Flt3 signaling (Liu and Nussenzweig, 2010) . The MPN was associated with reduced plasma cholesterol, and raising HDL levels though overexpression of the human apoA-I transgene partially prevented these defects. Our findings indicate that HDL-mediated cholesterol efflux pathways in macrophages and dendritic cells act to suppress HSPC mobilization and extramedullary hematopoiesis, and that HDL raising treatments could have beneficial effects on these processes in atherosclerosis and hematological malignancies. Treatments with rHDL (provided by CSL Australia) or vehicle (saline) were administered via the tail vein. All mice were housed at Columbia University Medical Center according to animal welfare guidelines. Mice were maintained on a 12 hr light/12 hr darkness lighting schedule. Animals had ad libitum access to both food and water.
Colony-Forming Assay
All experiments were performed between 12:00 and 1:00 p.m. to limit variability between experiments. For peripheral blood CFU assays, 300 ml of blood were collected into EDTA tubes before red blood cell lysis, filtration, and centrifugation for 5 min at 1,000 rpm. Splenocytes were extracted by pressing spleens through a stainless steel grid. Single-cell suspension was submitted to red blood cell lysis, filtration, and centrifugation for 5 min at 1,000 rpm. For liver, lung, and heart CFU assays, tissues were cut in small piece and digested with 1 mg/ml collagenase D (Roche) for 30 min at 37 C before red blood cell lysis, filtration, and centrifugation for 5 min at 1,000 rpm. Peripheral cells, splenocytes (5 3 10 4 ), liver, lung, and heart cells (1 3 10 6 ) were plated in methylcellulose-based media containing a cocktail of recombinant cytokines including SCF, IL-3, and IL-6 (Methocult, Stemcell) supplemented with 2% FCS to generate multipotential progenitor cells (CFU-GEMM) in presence or absence of 10% IL-3 supplement media (BD Bioscience) and GM-CSF (2 ng/ml) (Mix conditions) (R&D Systems) to generate granulocyte-macrophage progenitors (CFU-GMs). The number of CFUs per dish was scored after 10 days of differentiation.
Flow Cytometry Analysis and Cell Sorting BM cells, peripheral blood leukocytes, and splenocytes were collected as described above. Cells were stained with the appropriate antibodies for 30 min on ice. Intracellular stainings were performed using the Cytofix/ Cytoperm kit (BD Biosciences) according to the manufacturer's protocol. Endothelial cells, osteoblasts, and Nestin + cells were isolated at previously described (Semerad et al., 2005) . Briefly, tibias and femurs were flushed thoroughly of BM cells, chopped with a scalpel, and washed three times to further remove residual BM cells. The bone fragments were then digested with collagenase type IA (Sigma-Aldrich) for 30 min at 37 C before red blood cell lysis, filtration, and centrifugation for 5 min at 1,000 rpm. Multiparameter analyses of stained cell suspensions were performed on a four-laser BD LSRII cell analyzer or sorted on a BD FACSAria Cell Sorter both running with DiVa software (BD Biosciences). Viable cells were gated by light scatter or exclusion of CD45 À cells. Data were analyzed using FlowJo software (Tree Star Inc.).
Statistical Analysis
Statistical significance was assessed by performing two-tailed parametric Student's t test or one-way analysis of variance (ANOVA, four-group comparisons) with a Bonferroni multiple comparison post-test (GraphPad software, San Diego, CA). 
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